Avanos Medical (AVNS) EPS (Basic) Growth (3y) (2016 - 2026)
Avanos Medical (AVNS) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.52% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.60% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 3.18% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.89% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.34% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 29.37% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.65% |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -11.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.20% |
| Dec 31, 2024 | 76.98% |
| Sep 30, 2024 | 63.81% |
| Jun 30, 2024 | -27.41% |
| Mar 31, 2024 | 44.26% |
| Dec 31, 2023 | 78.13% |
| Sep 30, 2023 | -35.38% |
| Jun 30, 2023 | -179.01% |
| Mar 31, 2023 | 26.49% |
| Dec 31, 2021 | -274.30% |
| Jun 30, 2021 | 3.50% |
| Mar 31, 2021 | -31.24% |
| Dec 31, 2020 | -54.52% |
| Sep 30, 2020 | -11.00% |
| Jun 30, 2020 | -28.12% |
| Mar 31, 2020 | -49.28% |
| Dec 31, 2018 | -88.67% |
| Jun 30, 2018 | 61.41% |
| Mar 31, 2018 | 12.90% |
| Dec 31, 2017 | 139.67% |